Globe Life (NYSE:GL) Releases FY 2026 Earnings Guidance

Key Points

• Globe Life lowered its FY 2026 EPS guidance to $15.35–$15.65, below the $15.72 consensus estimate, while projecting FY 2027 EPS of $16.10–$17.10.
• Third-quarter revenue rose 5.5% year over year to $1.60 billion and exceeded estimates, but EPS of $4.84 missed consensus amid weaker underwriting results and higher expenses.
• Shares fell 6.3% to $157.79 following the guidance update. The company maintains a $2.5 billion share-repurchase authorization and pays a quarterly dividend of $0.33 per share.

Globe Life (NYSE:GL - Get Free Report) updated its FY 2026 earnings guidance on Friday morning. The company provided EPS guidance of 15.350-15.650 for the period, compared to the consensus EPS estimate of 15.720. Globe Life also updated its FY 2027 guidance to 16.100-17.100 EPS.

Globe Life Stock Down 6.3%

GL stock traded down $10.62 during mid-day trading on Friday, hitting $157.79. 321,277 shares of the company were exchanged, compared to its average volume of 542,148. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.07 and a current ratio of 0.07. Globe Life has a 1-year low of $127.85 and a 1-year high of $191.55. The firm's 50 day simple moving average is $170.48 and its 200 day simple moving average is $167.25. The firm has a market cap of $12.13 billion, a P/E ratio of 10.48 and a beta of 0.44.

Globe Life (NYSE:GL - Get Free Report) last released its quarterly earnings results on Wednesday, October 21st. The company reported $4.84 earnings per share for the quarter, missing the consensus estimate of $4.90 by ($0.06). Globe Life had a net margin of 18.89% and a return on equity of 19.95%. The company had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter last year, the company earned $4.81 EPS. The firm's quarterly revenue was up 5.5% compared to the same quarter last year. On average, sell-side analysts predict that Globe Life will post 15.70 EPS for the current fiscal year.

Globe Life Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be given a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life's payout ratio is currently 8.76%.

Globe Life announced that its board has approved a stock repurchase plan on Monday, August 10th that authorizes the company to buy back $2.50 billion in shares. This repurchase authorization authorizes the company to purchase up to 17.7% of its stock through open market purchases. Share repurchase plans are often an indication that the company's leadership believes its shares are undervalued.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Morgan Stanley lowered their target price on Globe Life from $208.00 to $197.00 and set an "overweight" rating for the company in a report on Monday, October 5th. Piper Sandler lowered Globe Life from an "overweight" rating to a "neutral" rating and set a $165.00 price target on the stock. in a report on Friday. Keefe, Bruyette & Woods reduced their price objective on Globe Life from $192.00 to $190.00 and set an "outperform" rating for the company in a research report on Friday, July 24th. Jefferies Financial Group increased their price objective on Globe Life from $147.00 to $166.00 and gave the stock a "hold" rating in a report on Friday, July 10th. Finally, Wells Fargo & Company lifted their target price on Globe Life from $190.00 to $191.00 and gave the company an "overweight" rating in a research report on Monday, October 12th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Globe Life presently has an average rating of "Moderate Buy" and a consensus target price of $182.60.

Insider Buying and Selling at Globe Life

In related news, CEO James Darden sold 50,000 shares of the stock in a transaction on Friday, July 31st. The shares were sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the completion of the transaction, the chief executive officer owned 58,451 shares in the company, valued at approximately $10,663,215.93. This represents a 46.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Hensley sold 10,000 shares of the firm's stock in a transaction on Tuesday, September 22nd. The shares were sold at an average price of $170.07, for a total transaction of $1,700,700.00. Following the completion of the transaction, the executive vice president directly owned 12,384 shares of the company's stock, valued at approximately $2,106,146.88. This trade represents a 44.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 143,650 shares of company stock worth $25,793,717. Company insiders own 2.11% of the company's stock.

Globe Life News Summary

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life reported third-quarter revenue of approximately $1.60 billion, above the $1.56 billion analyst consensus, with revenue up 5.5% year over year. Operating EPS increased to $4.84 from $4.81 a year earlier. Globe Life third-quarter 2026 results
• Positive Sentiment: Management is targeting $850 million to $950 million in parent excess cash flow for 2027, which could support capital returns, debt reduction or other shareholder-friendly actions. The company projects 2027 EPS of $16.10 to $17.10, a range that includes the $16.51 consensus estimate. Globe Life 2027 outlook
• Neutral Sentiment: The company’s 2027 EPS guidance of $16.10 to $17.10 implies continued earnings growth, but the broad range suggests uncertainty around operating performance and future underwriting results.
• Negative Sentiment: Third-quarter operating EPS of $4.84 missed estimates ranging from $4.87 to $4.90. Weaker underwriting income and higher expenses offset gains from increased premiums and investment income. Globe Life Q3 earnings miss
• Negative Sentiment: Globe Life cut its FY 2026 EPS outlook to $15.35-$15.65, below the $15.72 consensus estimate. Reports also cited losses at Evry Health as a factor pressuring the full-year guidance. Evry Health losses and Globe Life guidance
• Negative Sentiment: The quarter included a reported underwriting loss of about $6.4 million, raising investor concerns about claims trends, expense control and the company’s ability to convert premium growth into profits. Globe Life underwriting loss analysis

About Globe Life

Globe Life Inc NYSE: GL is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.

The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.